News Release

China Patent and Trademark Office Grants Patent for F351, GNI’s Key Therapeutic Product for Liver Disease

• China Patent and Trademark Office Grants Patent for F351,GNI’s Key Therapeutic Product for Liver Disease
• GNI Receives Patent Approval in China for Important Cancer Targets